Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-25 @ 5:35 PM
Study NCT ID:
NCT01066104
Status:
COMPLETED
Last Update Posted:
2017-06-14
First Post:
2010-02-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-08
First Submit QC Date:
None
Study First Post Date:
2010-02-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-24
Results First Submit QC Date:
None
Results First Post Date:
2017-05-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-19
Last Update Post Date:
2017-06-14
Last Update Post Date Type:
ACTUAL